NDC 1987-0706-26 · Rx only Highlights of prescribing information Rev. 07/2026

These highlights do not include all the information needed to work with NEIMA safely and effectively. See full prescribing information below.

Neima

(pharmacist-technologist) software, for human use

For the treatment of broken healthcare software

Initial U.S. deployment: 2015

Active ingredient
Clinical judgment, 100%
Dosage form
Full-stack engineer
Route of administration
Design → code → deploy
License
PharmD, actively practicing

Warning: clinical experience required

Healthcare software built without clinical experience has been associated with alert fatigue, abandoned workflows, and patient harm. Neima is a practicing pharmacist who writes production code — the two are administered together, at a single active site.

1 · Indications and usage

Indicated wherever medicine meets software.

Neima designs and builds healthcare applications end-to-end — from the first wireframe to the production deploy, as one person. A decade behind the pharmacy counter means the software starts from the workflow, not the other way around.

Also indicated for: independent pharmacies drowning in phone calls, clinicians tolerating decades-old tooling, and health-tech teams who need someone fluent in both HL7 and HTTP.

Limitations of use. Not indicated for engagement metrics, dark patterns, or software that treats clinicians as data-entry clerks.

2 · Dosage and administration

Titrate scope to workflow. Ship at steady state.

SIG · PO ONCE

Full product build

An app designed, engineered, and deployed end-to-end — from clinical logic to the pixel. Best taken when the workflow is understood and the vendor is not.

SIG · QW MAINTENANCE

Embedded pharmacist-engineer

Ongoing product work inside your team — a clinician in the repo, a maintenance dose of judgment where health-tech decisions get made.

SIG · STAT

Rescue mission

For legacy systems in acute distress. Stabilize the workflow, replace the failing component, discharge with better software.

3 · Mechanism of action

Dual-binding affinity: the clinic and the terminal.

Most builders of healthcare software have never verified a prescription at 6 pm on a Friday. Neima has — thousands of times — and then went home and built the software he wished existed. The mechanism is simple and rarely replicated: both binding sites, one molecule.

Site A — the counter

Pharmacist

Licensed PharmD, still practicing. Verification, counseling, immunizations — and the thousand small failures of pharmacy software witnessed firsthand, daily.

Site B — the terminal

Engineer

TypeScript, Swift, Python. HIPAA-first architecture, self-hosted infrastructure, native apps over wrappers. Designs it, builds it, ships it — alone.

SwiftUI TypeScript Python Postgres HIPAA Design C₈H₁₀N₄O₂-free · self-hosted
Figure 1. Structure of the NEIMA molecule. Clinical judgment at the active site; production code at every bond.

4 · Clinical applications

In production. In pharmacies. In use.

5 · Pharmacokinetics

Absorption was slow. Retention is complete.

Absorption

Pharmacy school

Doctor of Pharmacy. Pharmacology, therapeutics, and a durable suspicion of anything that interrupts patient care.

Distribution

The counter

A decade of verification queues, insurance rejections, and software that fights the clinician at every click.

Metabolism

The keyboard

Frustration converted into TypeScript, Swift, and Python. First tools, then apps, then pharmacies running on them.

Elimination

None observed

The pharmacist never left the building. Every product still starts at the counter, with the workflow.

6 · Clinical studies

Study RXC-01: the phone stopped ringing.

An open-label, real-world deployment of RefillCalls in an independent pharmacy. No placebo arm was ethical — the control condition was hold music. Enrollment ongoing.

Table 1 · Efficacy endpoints, as observed at the counter
EndpointResult
Primary — refill requests captured without a human on the line ● Met — the queue fills itself, around the clock
Secondary — pharmacist attention returned to patients ● Met — measured in uninterrupted counseling
Exploratory — staff opinion of the previous phone workflow Unprintable; collected verbatim
Results are observational, single-site, and thoroughly enjoyed. Replication under way at additional counters.

7 · Adverse reactions

Commonly reported, rarely regretted.

Very common (≥10%)
Fewer phone calls. Refills that queue themselves. Staff asking “can it also do…?”
Common (1–10%)
Workflow satisfaction. Sudden intolerance of the previous vendor.
Rare (<1%)
Feature requests at dinner parties.

To report a suspected reaction — or request one — contact neima@nakhaee.us.

8 · Warnings and precautions

Read before co-administering.

Electron wrappers. On Apple platforms, NEIMA exhibits strong preference for native SwiftUI over web-view wrappers. Co-administration may result in a rewrite.

Surrendered data. Contraindicated. Infrastructure is self-hosted by default; patient data stays where it belongs.

Switching from legacy vendors. Patients may experience abrupt relief. Taper is not required.

9 · How supplied / contact

Take one conversation, by email, as needed.

neima@nakhaee.us

Supplied as: one pharmacist-engineer, full-stack, self-hosted. Response within one business day. No prior authorization required.

Human-verified · No refills required